account-- Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for over-the-counter (OTC) Ranitidine 150 (regular and cool mint), a generic...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Perrigo Announces FDA Final Approval For Ranitidine 150 - Generic Equivalent To Zantac 150��
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account